ASEP Medical Holdings Inc. (SEPSF)
- Previous Close
0.0000 - Open
0.0600 - Bid 0.0020 x --
- Ask 0.1507 x --
- Day's Range
0.0600 - 0.0600 - 52 Week Range
0.0600 - 1.5000 - Volume
10,000 - Avg. Volume
16 - Market Cap (intraday)
4.305M - Beta (5Y Monthly) -1.94
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ASEP Medical Holdings Inc., together with its subsidiaries, focuses on developing diagnostic and therapeutic solutions for the treatment of sepsis. It offers peptide technology for therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and coatings for medical devices. The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to ASEP Medical Holdings Inc. in November 2021. ASEP Medical Holdings Inc. was incorporated in 2021 and is headquartered in Victoria, Canada.
asepmedical.comRecent News: SEPSF
View MorePerformance Overview: SEPSF
Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SEPSF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SEPSF
View MoreValuation Measures
Market Cap
4.02M
Enterprise Value
4.03M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
16.16
Price/Book (mrq)
0.57
Enterprise Value/Revenue
22.84
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-11.39%
Return on Equity (ttm)
-25.59%
Revenue (ttm)
243.92k
Net Income Avi to Common (ttm)
-4.64M
Diluted EPS (ttm)
-0.4300
Balance Sheet and Cash Flow
Total Cash (mrq)
52.69k
Total Debt/Equity (mrq)
1.47%
Levered Free Cash Flow (ttm)
795.94k